$43.52
2.30% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US92346J1088
Symbol
VCEL

Vericel Corporation Stock price

$43.52
+2.65 6.48% 1M
-13.74 24.00% 6M
-11.39 20.74% YTD
-7.61 14.88% 1Y
+16.13 58.89% 3Y
+28.64 192.47% 5Y
+40.39 1,290.42% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.98 2.30%
ISIN
US92346J1088
Symbol
VCEL
Sector

Key metrics

Market capitalization $2.19b
Enterprise Value $2.17b
P/E (TTM) P/E ratio 1,101.77
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 9.11
P/S ratio (TTM) P/S ratio 9.18
P/B ratio (TTM) P/B ratio 7.40
Revenue growth (TTM) Revenue growth 14.80%
Revenue (TTM) Revenue $238.54m
EBIT (operating result TTM) EBIT $-2.81m
Free Cash Flow (TTM) Free Cash Flow $-6.61m
Cash position $119.12m
EPS (TTM) EPS $0.04
P/E forward 177.63
P/S forward 7.66
EV/Sales forward 7.59
Short interest 11.94%
Show more

Is Vericel Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Vericel Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Vericel Corporation forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Vericel Corporation forecast:

Buy
100%

Financial data from Vericel Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
239 239
15% 15%
100%
- Direct Costs 66 66
3% 3%
27%
173 173
20% 20%
73%
- Selling and Administrative Expenses 143 143
20% 20%
60%
- Research and Development Expense 26 26
15% 15%
11%
4 4
61% 61%
2%
- Depreciation and Amortization 6.81 6.81
9% 9%
3%
EBIT (Operating Income) EBIT -2.81 -2.81
25% 25%
-1%
Net Profit 2.98 2.98
562% 562%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Vericel Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Vericel Corporation Stock News

Neutral
Investors Business Daily
one day ago
The top five biotech stocks today have several commonalities. Among them are strong ratings.
Neutral
Seeking Alpha
12 days ago
Vericel Corporation. (NASDAQ:VCEL ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Eric Burns - VP, Finance and IR Nick Colangelo - CEO Joe Mara - CFO Conference Call Participants Ryan Zimmerman - BTIG Richard Newitter - Truist Securities Josh Jennings - TD Cowen Caitlin Cronin - Canaccord Mason Carrico - Stephens Operator Thank you for standing by.
Neutral
GlobeNewsWire
13 days ago
Record First Quarter MACI Revenue of $46.3 Million and First Quarter Total Revenue of $52.6 Million Approximately 400 MACI Arthro Surgeons Trained to Date, with Year-to-Date Biopsy Growth Over 30% for Trained Surgeons Second Quarter Total Revenue and MACI Revenue Growth Expected to be in the Low- to Mid-20% Range Full-Year 2025 Revenue Guidance Reaffirmed and Profitability Guidance Raised Confe...
More Vericel Corporation News

Company Profile

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Head office United States
CEO Dominick Colangelo
Employees 357
Founded 1989
Website www.vcel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today